rs61733284

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_000292.3(PHKA2):​c.849T>A​(p.Ile283Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00293 in 1,208,421 control chromosomes in the GnomAD database, including 45 homozygotes. There are 995 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.013 ( 24 hom., 394 hem., cov: 23)
Exomes 𝑓: 0.0019 ( 21 hom. 601 hem. )

Consequence

PHKA2
NM_000292.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 2.16

Publications

0 publications found
Variant links:
Genes affected
PHKA2 (HGNC:8926): (phosphorylase kinase regulatory subunit alpha 2) Phosphorylase kinase is a polymer of 16 subunits, four each of alpha, beta, gamma and delta. The alpha subunit includes the skeletal muscle and hepatic isoforms, and the hepatic isoform is encoded by this gene. The beta subunit is the same in both the muscle and hepatic isoforms, and encoded by one gene. The gamma subunit also includes the skeletal muscle and hepatic isoforms, which are encoded by two different genes. The delta subunit is a calmodulin and can be encoded by three different genes. The gamma subunits contain the active site of the enzyme, whereas the alpha and beta subunits have regulatory functions controlled by phosphorylation. The delta subunit mediates the dependence of the enzyme on calcium concentration. Mutations in this gene cause glycogen storage disease type 9A, also known as X-linked liver glycogenosis. Alternatively spliced transcript variants have been reported, but the full-length nature of these variants has not been determined.[provided by RefSeq, Feb 2010]
PHKA2 Gene-Disease associations (from GenCC):
  • glycogen storage disease IXa1
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • glycogen storage disease due to liver phosphorylase kinase deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant X-18941544-A-T is Benign according to our data. Variant chrX-18941544-A-T is described in ClinVar as Benign. ClinVar VariationId is 255779.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.16 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.013 (1464/112491) while in subpopulation AFR AF = 0.042 (1302/30964). AF 95% confidence interval is 0.0402. There are 24 homozygotes in GnomAd4. There are 394 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 24 XL,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PHKA2NM_000292.3 linkc.849T>A p.Ile283Ile synonymous_variant Exon 8 of 33 ENST00000379942.5 NP_000283.1 P46019

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PHKA2ENST00000379942.5 linkc.849T>A p.Ile283Ile synonymous_variant Exon 8 of 33 1 NM_000292.3 ENSP00000369274.4 P46019

Frequencies

GnomAD3 genomes
AF:
0.0130
AC:
1462
AN:
112437
Hom.:
23
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0421
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00782
Gnomad ASJ
AF:
0.00452
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0125
Gnomad NFE
AF:
0.000731
Gnomad OTH
AF:
0.0165
GnomAD2 exomes
AF:
0.00428
AC:
786
AN:
183449
AF XY:
0.00271
show subpopulations
Gnomad AFR exome
AF:
0.0424
Gnomad AMR exome
AF:
0.00357
Gnomad ASJ exome
AF:
0.00561
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000757
Gnomad OTH exome
AF:
0.00552
GnomAD4 exome
AF:
0.00189
AC:
2073
AN:
1095930
Hom.:
21
Cov.:
29
AF XY:
0.00166
AC XY:
601
AN XY:
361332
show subpopulations
African (AFR)
AF:
0.0443
AC:
1168
AN:
26367
American (AMR)
AF:
0.00372
AC:
131
AN:
35206
Ashkenazi Jewish (ASJ)
AF:
0.00552
AC:
107
AN:
19371
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30193
South Asian (SAS)
AF:
0.000111
AC:
6
AN:
54092
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40526
Middle Eastern (MID)
AF:
0.0102
AC:
42
AN:
4131
European-Non Finnish (NFE)
AF:
0.000490
AC:
412
AN:
840034
Other (OTH)
AF:
0.00450
AC:
207
AN:
46010
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
80
160
240
320
400
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0130
AC:
1464
AN:
112491
Hom.:
24
Cov.:
23
AF XY:
0.0114
AC XY:
394
AN XY:
34655
show subpopulations
African (AFR)
AF:
0.0420
AC:
1302
AN:
30964
American (AMR)
AF:
0.00781
AC:
83
AN:
10632
Ashkenazi Jewish (ASJ)
AF:
0.00452
AC:
12
AN:
2655
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3594
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2726
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6155
Middle Eastern (MID)
AF:
0.0137
AC:
3
AN:
219
European-Non Finnish (NFE)
AF:
0.000731
AC:
39
AN:
53325
Other (OTH)
AF:
0.0163
AC:
25
AN:
1531
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
51
102
153
204
255
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00865
Hom.:
46
Bravo
AF:
0.0154
EpiCase
AF:
0.00104
EpiControl
AF:
0.000771

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Jun 09, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Feb 05, 2016
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Nov 29, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Glycogen storage disease IXa1 Benign:1
Dec 31, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.48
CADD
Benign
7.2
DANN
Benign
0.81
PhyloP100
2.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61733284; hg19: chrX-18959662; API